Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
Wiener klinische Wochenschrift
Erschienen in:

26.04.2022 | original article

New inflammatory biomarkers (lymphocyte and monocyte percentage to high-density lipoprotein cholesterol ratio and lymphocyte to monocyte percentage ratio) and their association with some cardiometabolic diseases

Results from a large Kurdish cohort study in Iran

verfasst von: Maryam Kohsari, Mehdi Moradinazar, Zohreh Rahimi, Farid Najafi, Yahya Pasdar, Ebrahim Shakiba

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 17-18/2022

Einloggen, um Zugang zu erhalten

Summary

Background

The incidence of metabolic heart diseases has increased significantly in Middle Eastern countries such as Iran. The present study aimed to investigate the association between monocyte percentage to high-density cholesterol ratio (MHR), lymphocyte percentage to high-density cholesterol ratio (LHR), and lymphocyte to monocyte percentage ratio (LMR) and cardiometabolic diseases in a Kurdish population in the west of Iran.

Methods

This study recruited 9803 individuals, 4728 (48.2%) were male and 5084 (51.8%) were female from Ravansar, Iran. All biomarkers were analyzed by the standard methods.

Results

The prevalence of cardiometabolic diseases was higher in overweight/obese participants and increased with age. MHR and LHR increased significantly in cardiometabolic individuals compared with healthy controls. Individuals in the fourth quartiles of LHR and MHR had higher odds ratio (ORs) for metabolic syndrome (MetS) and diabetes mellitus (DM) than the first quartiles. The LMR had a statistical association with non-alcoholic fatty liver disease (NAFLD) ORs and FLI. Besides, all these associations were stronger for females, and increased physical activity decreased inflammatory biomarkers.

Conclusion

The present study showed MHR and LHR had significant associations with ORs of MetS and DM. Also, MHR and LHR had a significant positive correlation with cardiometabolic risk factors. The LMR only had a statistical association with NAFLD and fatty liver index (FLI). Besides, the strong correlation between inflammatory biomarkers and cardiometabolic risk factors in females might be relevant to higher fat accumulation and metabolic inflammation background, and lower physical activity.
Vorheriger Artikel Postresuscitation care and prognostication after cardiac arrest—Does sex matter?
Nächster Artikel Clinical predictors of hyponatremia in patients with heart failure according to severity of chronic kidney disease
Literatur
1.
Sattar N, Gill JM, Alazawi W. Improving prevention strategies for cardiometabolic disease. Nat Med. 2020;263:320–5.CrossRef
2.
3.
4.
5.
Nichols GA, Horberg M, Koebnick C, et al. Cardiometabolic risk factors among 1.3 million adults with overweight or obesity, but not diabetes, in 10 geographically diverse regions of the United States, 2012–2013. Prev Chronic Dis. 2017;14:E22.PubMedPubMedCentralCrossRef
6.
Aksentijevich M, Lateef SS, Anzenberg P, et al. Chronic inflammation, cardiometabolic diseases and effects of treatment: psoriasis as a human model. Trends Cardiovasc Med. 2020;308:472–8.CrossRef
7.
Donath MY, Meier DT, Böni-Schnetzler M. Inflammation in the pathophysiology and therapy of cardiometabolic disease. Endocr Rev. 2019;404:1080–91.CrossRef
8.
Kantari C, Pederzoli-Ribeil M, Witko-Sarsat V. The role of neutrophils and monocytes in innate immunity. Trends Innate Immun. 2008;15:118–46.CrossRef
9.
Chapman CM, Beilby JP, McQuillan BM, et al. Monocyte count, but not C‑reactive protein or interleukin‑6, is an independent risk marker for subclinical carotid atherosclerosis. Stroke. 2004;357:1619–24.CrossRef
10.
Moro-García MA, Mayo JC, Sainz RM, et al. Influence of inflammation in the process of T lymphocyte differentiation: proliferative, metabolic, and oxidative changes. Front Immunol. 2018;9:339.PubMedPubMedCentralCrossRef
11.
Ely BR, Clayton ZS, McCurdy CE, et al. Meta-inflammation and cardiometabolic disease in obesity: can heat therapy help? Temperature. 2018;51:9–21.CrossRef
12.
Berg A, Scherer P. The Online version of this article, along with updated information and services, is located on the World Wide Web. JAHA. 2005;96:939–49.
13.
Osmond JM, Mintz JD, Dalton B, et al. Obesity increases blood pressure, cerebral vascular remodeling, and severity of stroke in the Zucker rat. Hypertension. 2009;532:381–6.CrossRef
14.
Ouchi N, Kihara S, Funahashi T, et al. Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol. 2003;146:561–6.CrossRef
15.
Shulman GI. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med. 2014;371(12):1131–41.PubMedCrossRef
16.
Zhu X, Parks JS. New roles of HDL in inflammation and hematopoiesis. Annu Rev Nutr. 2012;32:161–82.PubMedCrossRef
17.
Mousa H, Islam N, Ganji V, et al. Serum 25-hydroxyvitamin D is inversely associated with monocyte percentage to HDL cholesterol ratio among young healthy adults in qatar. Nutrients. 2021;131:127.
18.
Chen H, Xiong C, Shao X, et al. Lymphocyte to high-density lipoprotein ratio as a new indicator of inflammation and metabolic syndrome. Diabetes Metab Syndr Obes. 2019;12:2117.PubMedPubMedCentralCrossRef
19.
Kizilgül M, Çalişkan M, Uçan B, et al. Monocyte to HDL cholesterol ratio and its association with cardio-metabolic risk factors in primary hyperparathyroidism. Medeniyet Med J. 2018;332:94–9.
20.
Cekici Y, Yılmaz M, Seçen Ö. New inflammatory indicators: association of high eosinophil-to-lymphocyte ratio and low lymphocyte-to-monocyte ratio with smoking. J Int Med Res. 2019;479:4292–303.CrossRef
21.
22.
Sirin MC, Korkmaz S, Erturan I, et al. Evaluation of monocyte to HDL cholesterol ratio and other inflammatory markers in patients with psoriasis. An Bras Dermatol. 2020;95:575–82.PubMedPubMedCentralCrossRef
23.
24.
Acikgoz N, Kurtoğlu E, Yagmur J, et al. Elevated monocyte to high-density lipoprotein cholesterol ratio and endothelial dysfunction in Behçet disease. Angiology. 2018;691:65–70.CrossRef
25.
X‑b WCF, J‑l H, et al. Novel risk biomarker for infective endocarditis patients with normal left ventricular ejection fraction—monocyte to high-density lipoprotein cholesterol ratio. Circ J. 2017;821:283–8.
26.
Oh SW, Yi HJ, Lee DH, et al. Prognostic significance of various inflammation-based scores in patients with mechanical thrombectomy for acute ischemic stroke. World Neurosurg. 2020;141:e710–e7.PubMedCrossRef
27.
Asgari S, Moosaie F, Khalili D, et al. External validation of the European risk assessment tool for chronic cardio-metabolic disorders in a Middle Eastern population. J Transl Med. 2020;181:1–12.
28.
Pasdar Y, Najafi F, Moradinazar M, et al. Cohort profile: ravansar non-communicable disease cohort study: the first cohort study in a Kurdish population. Int J Epidemiol. 2019;483:682–3f.CrossRef
29.
30.
Aadahl M, Jørgensen T. Validation of a new self-report instrument for measuring physical activity. Med Sci Sports Exerc. 2003;357:1196–202.CrossRef
31.
Rajati F, Hamzeh B, Pasdar Y, et al. Prevalence, awareness, treatment, and control of hypertension and their determinants: results from the first cohort of non-communicable diseases in a Kurdish settlement. Sci Rep. 2019;91:1–10.
32.
Alberti K, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009;120(16):1640–5.PubMedCrossRef
33.
Chobanian AV. National heart, lung, and blood institute joint national committee on prevention, detection, evaluation, and treatment of high blood pressure; national high blood pressure education program coordinating committee: the seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560–72.PubMedCrossRef
34.
Huang X, Xu M, Chen Y, et al. Validation of the fatty liver index for nonalcoholic fatty liver disease in middle-aged and elderly Chinese. Medicine. 2015;94(40):e1682.PubMedPubMedCentralCrossRef
35.
Foster M, Samman S. Zinc and regulation of inflammatory cytokines: implications for cardiometabolic disease. Nutrients. 2012;47:676–94.CrossRef
36.
Marseglia L, Manti S, D’Angelo G, et al. Oxidative stress in obesity: a critical component in human diseases. IJMS. 2015;161:378–400.
37.
Yu S, Guo X, Li G, et al. Lymphocyte to high-density lipoprotein ratio but not platelet to lymphocyte ratio effectively predicts metabolic syndrome among subjects from rural China. Front Cardiovasc Med. 2021;8:107.
38.
Yamamoto S, Narita I, Kotani K. The macrophage and its related cholesterol efflux as a HDL function index in atherosclerosis. Clin Chimica Acta. 2016;457:117–22.CrossRef
39.
Hu Y, Zhang H, Li J, et al. Gut-derived lymphocyte recruitment to liver and induce liver injury in non-alcoholic fatty liver disease mouse model. J Gastroenterol Hepatol. 2016;313:676–84.CrossRef
40.
Zhang J, Chen W, Fang L, et al. Increased intermediate monocyte fraction in peripheral blood is associated with nonalcoholic fatty liver disease. Wien Klin Wochenschr. 2018;130(11-12):390–7.PubMedCrossRef
41.
42.
Onat A, Karadeniz Y, Tusun E, et al. Advances in understanding gender difference in cardiometabolic disease risk. Expert Rev Cardiovasc Ther. 2016;144:513–23.CrossRef
Metadaten
Titel
New inflammatory biomarkers (lymphocyte and monocyte percentage to high-density lipoprotein cholesterol ratio and lymphocyte to monocyte percentage ratio) and their association with some cardiometabolic diseases
Results from a large Kurdish cohort study in Iran
verfasst von
Maryam Kohsari
Mehdi Moradinazar
Zohreh Rahimi
Farid Najafi
Yahya Pasdar
Ebrahim Shakiba
Publikationsdatum
26.04.2022
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 17-18/2022
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-022-02029-8

Weitere Artikel der Ausgabe 17-18/2022

Postresuscitation care and prognostication after cardiac arrest—Does sex matter?

  • Open Access
  • original article

MUW researcher of the month

  • MUW researcher of the month

Refinement of data is needed concerning the long-term prognosis of patients with takotsubo syndrome

  • letter to the editors

Clinical predictors of hyponatremia in patients with heart failure according to severity of chronic kidney disease

  • original article

Impact of socioeconomic aspects on cardiac implantable electronic device treatment and application of the EHRA guidelines

  • original article

Reply to letter to the editors: The long-term prognosis of patients with takotsubo syndrome

  • letter to the editors